Literature DB >> 33743206

A DNA repair disorder caused by de novo monoallelic DDB1 variants is associated with a neurodevelopmental syndrome.

Susan M White1, Elizabeth Bhoj2, Christoffer Nellåker3, Augusta M A Lachmeijer4, Aren E Marshall5, Kym M Boycott5, Dong Li2, Wendy Smith6, Taila Hartley5, Arran McBride5, Michelle E Ernst7, Alison S May8, Dagmar Wieczorek9, Rami Abou Jamra10, Margarete Koch-Hogrebe11, Katrin Õunap12, Sander Pajusalu12, K L I van Gassen4, Simon Sadedin13, Sara Ellingwood6, Tiong Yang Tan14, John Christodoulou15, Jaime Barea16, Paul J Lockhart15, Marjan M Nezarati17, Kristin D Kernohan18.   

Abstract

The DNA damage-binding protein 1 (DDB1) is part of the CUL4-DDB1 ubiquitin E3 ligase complex (CRL4), which is essential for DNA repair, chromatin remodeling, DNA replication, and signal transduction. Loss-of-function variants in genes encoding the complex components CUL4 and PHIP have been reported to cause syndromic intellectual disability with hypotonia and obesity, but no phenotype has been reported in association with DDB1 variants. Here, we report eight unrelated individuals, identified through Matchmaker Exchange, with de novo monoallelic variants in DDB1, including one recurrent variant in four individuals. The affected individuals have a consistent phenotype of hypotonia, mild to moderate intellectual disability, and similar facies, including horizontal or slightly bowed eyebrows, deep-set eyes, full cheeks, a short nose, and large, fleshy and forward-facing earlobes, demonstrated in the composite face generated from the cohort. Digital anomalies, including brachydactyly and syndactyly, were common. Three older individuals have obesity. We show that cells derived from affected individuals have altered DDB1 function resulting in abnormal DNA damage signatures and histone methylation following UV-induced DNA damage. Overall, our study adds to the growing family of neurodevelopmental phenotypes mediated by disruption of the CRL4 ubiquitin ligase pathway and begins to delineate the phenotypic and molecular effects of DDB1 misregulation.
Copyright © 2021 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRL4; DDB1; intellectual disability; mutation

Mesh:

Substances:

Year:  2021        PMID: 33743206      PMCID: PMC8059373          DOI: 10.1016/j.ajhg.2021.03.007

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

Review 1.  DNA damage sensing by the ATM and ATR kinases.

Authors:  Alexandre Maréchal; Lee Zou
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

Review 2.  Structure and function of WD40 domain proteins.

Authors:  Chao Xu; Jinrong Min
Journal:  Protein Cell       Date:  2011-04-06       Impact factor: 14.870

3.  A genotype-first approach identifies an intellectual disability-overweight syndrome caused by PHIP haploinsufficiency.

Authors:  Sandra Jansen; Alexander Hoischen; Bradley P Coe; Gemma L Carvill; Hilde Van Esch; Daniëlle G M Bosch; Ulla A Andersen; Carl Baker; Marijke Bauters; Raphael A Bernier; Bregje W van Bon; Hedi L Claahsen-van der Grinten; Jozef Gecz; Christian Gilissen; Lucia Grillo; Anna Hackett; Tjitske Kleefstra; David Koolen; Malin Kvarnung; Martin J Larsen; Carlo Marcelis; Fiona McKenzie; Marie-Lorraine Monin; Caroline Nava; Janneke H Schuurs-Hoeijmakers; Rolph Pfundt; Marloes Steehouwer; Servi J C Stevens; Connie T Stumpel; Fleur Vansenne; Mirella Vinci; Maartje van de Vorst; Petra de Vries; Kali Witherspoon; Joris A Veltman; Han G Brunner; Heather C Mefford; Corrado Romano; Lisenka E L M Vissers; Evan E Eichler; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2017-12-05       Impact factor: 4.246

4.  DDB1 is essential for genomic stability in developing epidermis.

Authors:  Yong Cang; Jianxuan Zhang; Sally A Nicholas; Arianna L Kim; Pengbo Zhou; Stephen P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-14       Impact factor: 11.205

5.  DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.

Authors:  Xin Tong; Deqiang Zhang; Nicholas Charney; Ethan Jin; Kyle VanDommelen; Kenneth Stamper; Neil Gupta; Johnny Saldate; Lei Yin
Journal:  Diabetes       Date:  2017-08-08       Impact factor: 9.461

6.  mTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase.

Authors:  Papia Ghosh; Min Wu; Hui Zhang; Hong Sun
Journal:  Cell Cycle       Date:  2007-11-02       Impact factor: 4.534

7.  DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources.

Authors:  Helen V Firth; Shola M Richards; A Paul Bevan; Stephen Clayton; Manuel Corpas; Diana Rajan; Steven Van Vooren; Yves Moreau; Roger M Pettett; Nigel P Carter
Journal:  Am J Hum Genet       Date:  2009-04-02       Impact factor: 11.025

8.  De novo PHIP-predicted deleterious variants are associated with developmental delay, intellectual disability, obesity, and dysmorphic features.

Authors:  Emily Webster; Megan T Cho; Nora Alexander; Sonal Desai; Sakkubai Naidu; Mir Reza Bekheirnia; Andrea Lewis; Kyle Retterer; Jane Juusola; Wendy K Chung
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-11

9.  Structural basis of UV DNA-damage recognition by the DDB1-DDB2 complex.

Authors:  Andrea Scrima; Renata Konícková; Bryan K Czyzewski; Yusuke Kawasaki; Philip D Jeffrey; Regina Groisman; Yoshihiro Nakatani; Shigenori Iwai; Nikola P Pavletich; Nicolas H Thomä
Journal:  Cell       Date:  2008-12-26       Impact factor: 41.582

10.  COSMIC: the Catalogue Of Somatic Mutations In Cancer.

Authors:  John G Tate; Sally Bamford; Harry C Jubb; Zbyslaw Sondka; David M Beare; Nidhi Bindal; Harry Boutselakis; Charlotte G Cole; Celestino Creatore; Elisabeth Dawson; Peter Fish; Bhavana Harsha; Charlie Hathaway; Steve C Jupe; Chai Yin Kok; Kate Noble; Laura Ponting; Christopher C Ramshaw; Claire E Rye; Helen E Speedy; Ray Stefancsik; Sam L Thompson; Shicai Wang; Sari Ward; Peter J Campbell; Simon A Forbes
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.